Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
To elucidate the deregulated functional modules that drive clear cell renal cell carcinoma (ccRCC), we performed comprehensive genomic, epigenomic, transcriptomic, proteomic, and phosphoproteomic characterization of treatment-naive ccRCC and paired normal adjacent tissue samples. Genomic analyses id...
Saved in:
Published in | Cell Vol. 179; no. 4; pp. 964 - 983.e31 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
31.10.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 0092-8674 1097-4172 1097-4172 |
DOI | 10.1016/j.cell.2019.10.007 |
Cover
Summary: | To elucidate the deregulated functional modules that drive clear cell renal cell carcinoma (ccRCC), we performed comprehensive genomic, epigenomic, transcriptomic, proteomic, and phosphoproteomic characterization of treatment-naive ccRCC and paired normal adjacent tissue samples. Genomic analyses identified a distinct molecular subgroup associated with genomic instability. Integration of proteogenomic measurements uniquely identified protein dysregulation of cellular mechanisms impacted by genomic alterations, including oxidative phosphorylation-related metabolism, protein translation processes, and phospho-signaling modules. To assess the degree of immune infiltration in individual tumors, we identified microenvironment cell signatures that delineated four immune-based ccRCC subtypes characterized by distinct cellular pathways. This study reports a large-scale proteogenomic analysis of ccRCC to discern the functional impact of genomic alterations and provides evidence for rational treatment selection stemming from ccRCC pathobiology.
[Display omitted]
•Integrated proteogenomic characterization in 103 ccRCC cases•Delineation of chromosomal translocation events leading to chromosome 3p loss•Tumor-specific proteomic/phosphoproteomic alterations unrevealed by mRNA analysis•Immune-based subtypes of ccRCC defined by mRNA, proteome, and phosphoproteome
Comprehensive proteogenomic characterization in 103 treatment-naive clear cell renal cell carcinoma patient samples highlights tumor-specific alterations at the proteomic level that are unrevealed by transcriptomic profiling and proposes a revised subtyping scheme based on integrated omics analysis. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 AUTHOR CONTRIBUTIONS Conceptualization, H.R., D.C., A.I.N., P.W., and H.Z.; Methodology, D.J.C. and L.C.; Software, F.P., J.P., X.S., Y.H., F.d.V.L., B.R., T.-S.M.L., H.-Y.C., W.M., C.H., A. Krek, Y.L., D.R., L.S.C., U.O., S.V., S.Y., S. Chowdhury, J.J., A. Kong, S.S., D.M.A., N.E., Z.Z., M.C., A.I.N., and P.W.; Validation, S.M.D., K.L.Q., and K.-C.C.; Formal Analysis, D.J.C., S.M.D., F.P., J.P., X.S., Y.H., B.R., T.-S.M.L., H.-Y.C., W.M., C.H., A. Krek, Y.L., D.R., L.S.C., U.O., S.V., Y.W., S.Y., S. Chowdhury, J.J., A. Kong, S.S., D.M.A., A. Colaprico, S. Cao, S. Kalayci, S.M., W.L., K.R., D.G., E.K., G.C.T., B.W., Y.Z., S. Keegan, K.L., F.C., N.E., A.I.N., P.W., and H.Z.; Investigation, D.J.C., L.C., M.S., K.-C.C., D.W.C., and H.Z.; Resources, Q.K.L., C.P.P., G.B., A.A., J.L., and M.T.; Data Curation, D.J.C., S.M.D., W.M., M.A.W., M.S., M.A., M.C., A.I.N., P.W., and H.Z.; Writing – Original Draft, D.J.C., A.I.N., P.W., and H.Z.; Writing – Review & Editing, all authors; Visualization, D.J.C., S.M.D., F.P., J.P., X.S., Y.H., B.R., T.-S.M.L., C.H., C.J.R., A. Krek, Y.L., D.R., U.O., S.V., M.A., A. Calinawan, Z.H.G., Y.Z., and M.C.; Supervision, D.J.C., S.M.D., C.J.R., P.M.P., X.S.C., C.P.P., A.A.H, G.B., J.H., A.A., T.O., J.L., M.W., W.M.L., J.Q., D.F., B.Z., L.D., E.S., A.M.C., Z.Z., G.S.O., D.W.C., A.I.N., P.W., and H.Z.; Project Administration, D.J.C., C.R.K., M.T., M.M., E.S.B., M.M., T.H., A.I.R., H.R., D.W.C., A.I.N., P.W., and H.Z.; Funding Acquisition, B.Z., L.D., D.F., E.S., A.M.C., Z.Z., D.W.C., A.I.N., P.W., and H.Z. |
ISSN: | 0092-8674 1097-4172 1097-4172 |
DOI: | 10.1016/j.cell.2019.10.007 |